US Patent Issued to GABA Therapeutics on Oct. 7 for "Deuterated analogs of etifoxine, their derivatives and uses thereof" (California Inventor)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,896, issued on Oct. 7, was assigned to GABA Therapeutics Inc. (Newport Beach, Calif.).

"Deuterated analogs of etifoxine, their derivatives and uses thereof" was invented by Olivier Dasse (Foothills Ranch, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to deuterated analogs of etifoxine of Formula 1, solvates, prodrugs, and pharmaceutically acceptable salts thereof, as well as to methods for their preparation and use, and to pharmaceutical compositions. Briefly, this invention is generally directed to deuterated analogs of etifoxine as well as to methods for their preparation and use, and to pharmaceutical compositions co...